Progressive disease | Partial remission | |
---|---|---|
Female:male | 6:1 | 3:3 |
Age (years) | 50 (39–55) | 57 (42–60) |
Duration of vasculitis (months) | 6 (1–104) | 43 (26–67) |
ESR (mm/h) | 28 (16–72) | 14 (3–16) |
C-reactive protein (mg/dl) | 1.7 (0.6–11.7) | 0.5 (0.4–0.7) |
Blood eosinophil count (cells/μl) | 1470 (550–2560) | 170 (100–210) |
Disease extent index (DEI score) | 5 (3–9) | 4 (4–6) |
Cumulative organ involvement (n) | ||
Upper respiratory tract | 7 | 6 |
Arthritis | 3 | 4 |
Polyneuropathy | 4 | 4 |
Kidney | 0 | 1 |
Skin | 4 | 3 |
Heart | 3 | 3 |
Gastrointestinal | 1 | 2 |
Myositis | 0 | 1 |
VCIN (% predicted) | 97 (78–102) | 92 (67–100) |
FEV1/VCIN (%) | 70 (67–75) | 67 (43–70) |
Tlco/Va(% predicted) | 88 (71–92) | 84 (77–87) |
VCIN = inspiratory vital capacity; FEV1 = forced expiratory volume in one second; Tlco = carbon monoxide transfer factor; Va = alveolar volume.
Values are median (interquartile range).